Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
10/2010
10/07/2010US20100255011 Compositions and methods for modulating the activity of complement regulatory proteins on target cells
10/07/2010US20100255010 Anti-her antibodies
10/07/2010US20100255009 Methods for Inducing Mixed Donor-Recipient Chimerism in an Allograft Transplant Recipient
10/07/2010US20100255008 Antibodies against human tweak and uses thereof
10/07/2010US20100255007 Therapeutic agents for graft-versus-host disease comprising interleukin 6 receptor inhibitor as active ingredient
10/07/2010US20100255006 Novel molecules of the pyrin/nbs/lrr protein family and uses thereof
10/07/2010US20100255005 Gamma secretase modulators
10/07/2010US20100255004 Receptor tyrosine kinase profiling
10/07/2010US20100255003 Immune Disease Medicament Comprising a Modulator of the Binding Between a Heparin Bindin Domain of Thrombospondin-1 and a Beta1 Integrin
10/07/2010US20100255002 Immunogenic compositions for chlamydia trachomatis
10/07/2010US20100255001 Blockers of serotonin and its receptors for the treatment of hepatitis
10/07/2010US20100255000 Antidotes for factor xa inhibitors and methods of using the same
10/07/2010US20100254999 Eg-vegf nucleic acids and polypeptides and methods of use
10/07/2010US20100254998 Method for prolonging longevity
10/07/2010US20100254997 ADAMTS4 as a blood biomarker and therapeutic target for chronic renal failure
10/07/2010US20100254996 Synergistic treatment of cells that express epha2 and erbb2
10/07/2010US20100254995 Polypeptides, antibody variable domains and antagonists
10/07/2010US20100254994 Compositions and Methods for Binding or Inactivating Ghrelin
10/07/2010US20100254993 Human monoclonal antibodies against human il-4
10/07/2010US20100254992 Anti-mcp-1 antibodies, compositions, methods and uses
10/07/2010US20100254991 Use of Cytokine Expression to Predict Skin Inflammation; Methods of Treatment
10/07/2010US20100254990 Anti-ngf antibodies for the treatment of various disorders
10/07/2010US20100254989 Bispecific Anti ErbB1 / Anti c Met Antibodies
10/07/2010US20100254988 Bispecific Anti ErbB2 / Anti cMet Antibodies
10/07/2010US20100254987 Engineered proteins with high affinity for dota chelates
10/07/2010US20100254986 Method for making heteromultimeric polypeptides
10/07/2010US20100254985 Protein Formulations
10/07/2010US20100254984 Fusion constructs containing active sections of tnf ligands
10/07/2010US20100254983 Uses of rage antagonists for treating obesity and related diseases
10/07/2010US20100254982 Cancer specific antibody and cell surface proteins
10/07/2010US20100254981 Secreted/Cell Bound Poxvirus Proteins and Methods of Use Thereof as Vaccines and Anti-Viral Agents
10/07/2010US20100254980 Molecules and methods for modulating low-density-lipoprotein receptor-related protein 6 (lrp6)
10/07/2010US20100254979 Humanized PAI-1 Antibodies and Uses Thereof
10/07/2010US20100254978 Antibody molecules having specificity for human ox40
10/07/2010US20100254977 Engineered anti-alpha v-integrin hybrid antibodies
10/07/2010US20100254976 Use of protease nexin 1 inhibitors to reduce metastasis
10/07/2010US20100254975 Alpha-4 beta-7 heterodimer specific
10/07/2010US20100254974 Modulation of Immunostimulatory Properties of Oligonucleotide-Based Compounds by Optimal Presentation of 5' Ends
10/07/2010US20100254973 Materials and Methods for Diagnosis of Asthma
10/07/2010US20100254972 Methods for selecting protease resistant polypeptides
10/07/2010US20100254971 Method for Diagnosing Prognosing Inflammatory Bowel Disease and Crohn's Disease
10/07/2010US20100254970 Ngal for reduction and amelioration of ischemic and nephrotoxic injuries
10/07/2010US20100254964 Modified Bouganin Proteins, Cytotoxins and Methods and Uses Thereof
10/07/2010US20100254945 Rnai Therapeutic for Respiratory Virus Infection
10/07/2010US20100254941 Interleukin-18 binding proteins, their preparation and use for the treatment of sepsis
10/07/2010US20100254901 Compositions comprising nucleic acid aptamers
10/07/2010US20100254900 Biocompatible polymers and Methods of use
10/07/2010DE102005028271B4 Proteingemisch enthaltend VSV-G zur Verstärkung der Immunantwort Mixture comprising VSV-G protein to enhance the immune response
10/07/2010CA2794577A1 Semaphorin 3c (sema3c) inhibitor therapeutics, methods, and uses
10/07/2010CA2759942A1 Composition and methods of use for therapeutic antibodies specific for the il-12 receptore betai subunit
10/07/2010CA2757306A1 Formulation
10/07/2010CA2757210A1 C6orf167 peptides and vaccines containing the same
10/07/2010CA2757114A1 Preparation of isolated agonist anti-edar monoclonal antibodies
10/07/2010CA2757095A1 Bmp-alk3 antagonists and uses for promoting bone growth
10/07/2010CA2756996A1 Vaccine compositions and methods of use thereof
10/07/2010CA2756988A1 Anti-fcrh5 antibodies and immunoconjugates and methods of use
10/07/2010CA2756889A1 Monoclonal antibody capable of binding to specific discontinuous epitope occurring in ad1 region of human cytomegalovirus gb glycoprotein, and antigen-binding fragment thereof
10/07/2010CA2756762A1 Adenylyl cyclase-associated protein (cap1) and uses thereof as a target for immuno-modulation
10/07/2010CA2756238A1 Identification, optimization and use of cryptic hla-a24 epitopes for immunotherapy
10/07/2010CA2754646A1 Treatment of cancer with a humanized anti-egfr igg1 antibody and irinotecan
10/07/2010CA2752908A1 Treatment of insulin-resistant disorders
10/07/2010CA2749512A1 Antigenic determinants recognized by anti-human death receptor dr5 monoclonal antibody ad5-10, derivatives and use thereof
10/06/2010EP2236605A1 Human anti- 9 integrin antibody
10/06/2010EP2236604A1 Anti-nr10 antibody and use thereof
10/06/2010EP2236519A1 Human GM-CSF antigen binding proteins
10/06/2010EP2236518A2 Humaneered anti-factor B antibody
10/06/2010EP2236515A1 Component protein pa1698 for type-iii secretion system of pseudomonas aeruginosa
10/06/2010EP2236172A1 Combination therapy comprising anti-CD20 and anti-CD40 antibodies for the treatment of B cell-related cancers
10/06/2010EP2236156A2 Methods for treating and diagnosing Psoriasis
10/06/2010EP2236155A1 Decreasing potential iatrogenic risks associated with influenza vaccines
10/06/2010EP2236154A1 Immunoglobulin formulation and method of preparation thereof
10/06/2010EP2236152A1 Albumin fusion proteins
10/06/2010EP2236139A1 Combination therapy of erlotinib with an anti-IGF-1R antibody, which does not inhibit binding of insulin to the insulin receptor
10/06/2010EP2235189A1 Methods for inhibiting angiogenesis using egfl8 antagonists
10/06/2010EP2235163A1 Recombinant bcg tuberculosis vaccine for eliciting immune responses to mycobacterium tuberculosis
10/06/2010EP2235159A2 Fermentation processes for cultivating streptococci and purification processes for obtaining cps therefrom
10/06/2010EP2235062A1 Improved anti-trkb antibodies
10/06/2010EP2235061A1 Afucosylated antibodies against ccr5 and their use
10/06/2010EP2235058A2 Anti-amyloid antibodies and uses thereof
10/06/2010EP2235057A2 G immunoglobulin used against anthrax toxins
10/06/2010EP2235046A2 Mutant forms of streptolysin o
10/06/2010EP2234641A2 Monoclonal antibodies against cd32b
10/06/2010EP2234636A1 Stabilized formulations of peptides and proteins
10/06/2010EP2234635A2 Rhoc-based immunotherapy
10/06/2010EP2234497A2 Bacteriophage preparation and use
10/06/2010EP1871415B1 Composition for treating cancer adapted for intra-tumoral asministration and uses thereof
10/06/2010EP1736484B1 An gene engineering recombinant anti-cea, anti-cd3 and anti-cd28 single-chain tri-specific antibody
10/06/2010EP1569687B1 Coccidial vaccine and methods of making and using same
10/06/2010EP1551449B1 Reagents and methods for engaging unique clonotypic lymphocyte receptors
10/06/2010EP1513554B1 Cd16a binding proteins and use for the treatment of immune disorders
10/06/2010EP1456650B1 Gfats as modifiers of the p53 pathway and methods of use
10/06/2010EP1220906B1 Polynucleotides encoding members of the human b lymphocyte activation antigen b7 family and polypeptides encoded thereby
10/06/2010EP0873363B1 High affinity human antibodies to tumor antigens
10/06/2010CN1887350B Recombinant vaccine and its use
10/06/2010CN1646684B Recombinant parainfluenza virus expression systems and vaccines comprising heterologous antigens derived from metapneumovirus
10/06/2010CN1522516B Secure header information for multi-content e-mail
10/06/2010CN101855349A West nile virus vaccine, and method for production thereof
10/06/2010CN101855339A Human cancer stem cells
10/06/2010CN101855244A Novel antibodies
10/06/2010CN101855238A Fusion protein vaccine
1 ... 485 486 487 488 489 490 491 492 493 494 495 496 497 498 499 500 501 502 503 504 505 ... 1823